PROTERIXBIO

ProterixBio has developed a novel combination of blood-based biomarkers for identifying COPD populations at higher risk for severe exacerbation, collaborating with leading academic medical centers and validating our assay in large, carefully curated cohorts... Our highly experienced team partners with our clients to deliver immunoassay or protein biomarker testing solutions from our Billerica, MA CLIA-certified laboratory (licensed in all 50 States). We serve hospital / medical centers, biotech / pharma and diagnostic testing businesses to meet advanced research and clinical testing needs... offering of the Presage® ST2 Assay as a testing service through ProterixBio's high-complexity CLIA laboratory. This Assay has been FDA cleared for use in conjunction with clinical evaluation as an aid in assessing the prognosis of patients diagnosed with chronic heart failure.

Also known as: ProterixBio, Inc., The ProterixBio

Primary location: Billerica United States